Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
27.42
-1.23 (-4.29%)
May 18, 2026, 4:00 PM EDT - Market closed
Assembly Biosciences Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Assembly Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $48.75. The average 1-year stock price forecast is 77.79% higher than the current stock price, while the lowest is $40 (+45.88%) and the highest is $62 (+126.11%).
Price Target: $48.75 (+77.79%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Assembly Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +82.35% | May 4, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $39 → $43 | Strong Buy | Maintains | $39 → $43 | +56.82% | Apr 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +82.35% | Mar 26, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +82.35% | Dec 22, 2025 |
| Mizuho | Mizuho | Buy Maintains $29 → $40 | Buy | Maintains | $29 → $40 | +45.88% | Nov 20, 2025 |
Financial Forecast
Revenue This Year
18.76M
from 72.30M
Decreased by -74.06%
Revenue Next Year
28.82M
from 18.76M
Increased by 53.63%
EPS This Year
-3.05
from -0.55
EPS Next Year
-2.76
from -3.05
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 43.2M | 79.3M | ||||||
| Avg | 18.8M | 28.8M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -40.2% | 322.7% | ||||||
| Avg | -74.1% | 53.6% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.91 | -0.67 | ||||||
| Avg | -3.05 | -2.76 | ||||||
| Low | -4.08 | -5.01 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.